The approaches to the assessment of biosimilarity of biotechnological preparations: quality issues
Due to expiration of patents for most highly demanded biotechnological preparations there is a tendency for the increase in the number of applications for marketing authorisation of biosimilar preparations (biosimilars). In the Russian Federation, the process of bringing biosimilars to the market ha...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2018-02-01
|
| Series: | Регуляторные исследования и экспертиза лекарственных средств |
| Subjects: | |
| Online Access: | https://www.vedomostincesmp.ru/jour/article/view/19 |
| _version_ | 1826566790100025344 |
|---|---|
| author | A. N. Mironov V. A. Merkulov A. I. Lutseva O. A. Vaganova A. A. Bendryshev T. A. Efremova E. V. Kirichenko S. V. Shvets E. V. Ivanainen |
| author_facet | A. N. Mironov V. A. Merkulov A. I. Lutseva O. A. Vaganova A. A. Bendryshev T. A. Efremova E. V. Kirichenko S. V. Shvets E. V. Ivanainen |
| author_sort | A. N. Mironov |
| collection | DOAJ |
| description | Due to expiration of patents for most highly demanded biotechnological preparations there is a tendency for the increase in the number of applications for marketing authorisation of biosimilar preparations (biosimilars). In the Russian Federation, the process of bringing biosimilars to the market has just started. It should be expected that in the upcoming years the global tendency for brining biosimilars of previously authorized preparations will become real in Russia. In this regard there is a need for developing national requirements for drugs submitted for marketing authorization as biosimilars. In the present article the authors propose for consideration main approaches for selecting criteria for confirmation of biosimilarity in terms of their quality assessment and determining the amount of studies required to confirm the similarity and comparability of physical, chemical and biological properties of biosimilars in comparison with the originator. |
| first_indexed | 2024-03-07T19:18:28Z |
| format | Article |
| id | doaj.art-d09031cbd2a24a88b3043be9a0995d3f |
| institution | Directory Open Access Journal |
| issn | 3034-3062 3034-3453 |
| language | Russian |
| last_indexed | 2025-03-14T10:57:14Z |
| publishDate | 2018-02-01 |
| publisher | Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) |
| record_format | Article |
| series | Регуляторные исследования и экспертиза лекарственных средств |
| spelling | doaj.art-d09031cbd2a24a88b3043be9a0995d3f2025-03-02T10:46:39ZrusFederal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)Регуляторные исследования и экспертиза лекарственных средств3034-30623034-34532018-02-010141017The approaches to the assessment of biosimilarity of biotechnological preparations: quality issuesA. N. Mironov0V. A. Merkulov1A. I. Lutseva2O. A. Vaganova3A. A. Bendryshev4T. A. Efremova5E. V. Kirichenko6S. V. Shvets7E. V. Ivanainen8Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian FederationDue to expiration of patents for most highly demanded biotechnological preparations there is a tendency for the increase in the number of applications for marketing authorisation of biosimilar preparations (biosimilars). In the Russian Federation, the process of bringing biosimilars to the market has just started. It should be expected that in the upcoming years the global tendency for brining biosimilars of previously authorized preparations will become real in Russia. In this regard there is a need for developing national requirements for drugs submitted for marketing authorization as biosimilars. In the present article the authors propose for consideration main approaches for selecting criteria for confirmation of biosimilarity in terms of their quality assessment and determining the amount of studies required to confirm the similarity and comparability of physical, chemical and biological properties of biosimilars in comparison with the originator.https://www.vedomostincesmp.ru/jour/article/view/19оригинальный биотехнологический лекарственный препаратбиоаналоговый (биоподобный) лекарственный препараткачествоисследования сопоставимостипроизводстворегистрацияoriginal biotechnological productsbiosimilarqualitycomparability studiesmanufacturemarketing authorization |
| spellingShingle | A. N. Mironov V. A. Merkulov A. I. Lutseva O. A. Vaganova A. A. Bendryshev T. A. Efremova E. V. Kirichenko S. V. Shvets E. V. Ivanainen The approaches to the assessment of biosimilarity of biotechnological preparations: quality issues Регуляторные исследования и экспертиза лекарственных средств оригинальный биотехнологический лекарственный препарат биоаналоговый (биоподобный) лекарственный препарат качество исследования сопоставимости производство регистрация original biotechnological products biosimilar quality comparability studies manufacture marketing authorization |
| title | The approaches to the assessment of biosimilarity of biotechnological preparations: quality issues |
| title_full | The approaches to the assessment of biosimilarity of biotechnological preparations: quality issues |
| title_fullStr | The approaches to the assessment of biosimilarity of biotechnological preparations: quality issues |
| title_full_unstemmed | The approaches to the assessment of biosimilarity of biotechnological preparations: quality issues |
| title_short | The approaches to the assessment of biosimilarity of biotechnological preparations: quality issues |
| title_sort | approaches to the assessment of biosimilarity of biotechnological preparations quality issues |
| topic | оригинальный биотехнологический лекарственный препарат биоаналоговый (биоподобный) лекарственный препарат качество исследования сопоставимости производство регистрация original biotechnological products biosimilar quality comparability studies manufacture marketing authorization |
| url | https://www.vedomostincesmp.ru/jour/article/view/19 |
| work_keys_str_mv | AT anmironov theapproachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT vamerkulov theapproachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT ailutseva theapproachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT oavaganova theapproachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT aabendryshev theapproachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT taefremova theapproachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT evkirichenko theapproachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT svshvets theapproachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT evivanainen theapproachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT anmironov approachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT vamerkulov approachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT ailutseva approachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT oavaganova approachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT aabendryshev approachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT taefremova approachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT evkirichenko approachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT svshvets approachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues AT evivanainen approachestotheassessmentofbiosimilarityofbiotechnologicalpreparationsqualityissues |